- Sequana Medical NV press release (OTC:SQNMF): FY GAAP EPS of -€1.22.
- Revenue of €0.71M (-22.8% Y/Y).
- Earnings before interest and taxes remained broadly unchanged from a loss of €28.09 million in 2022 to a loss of €28.86 million in 2023.
- The company ended 2023 with a total cash and cash equivalents amount of €2.58 million (2022: €18.87 million).